Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study.

Paola Queirolo,Emilia Cocorocchio,Pietro Quaglino,Ester Simeone,Anna Morabito,Paolo Marchetti,Chiara Martinoli,Maria Pia Pistillo,Stefania Tommasi,Vincenzo Fontana,Massimo Romani,Cristiana Fava,Barbara Banelli,Michele Guida,Pier Francesco Ferrucci,Barbara Merelli,Patrizia Piccioli,Paolo Fava,Stefania Laurent,Mariaelena Capone,Gian Carlo Antonini Cappellini,Elena Pagani,Francesco Spagnolo,Paolo A Ascierto,Mario Mandalà,Federica De Galitiis,Roberta Carosio,Massimo Giusti ,Béatrice Dozin ,Agatino Battaglia ,C Di Leo

doi:10.3389/fimmu.2018.00403

Abstract

[This corrects the article on p. 386 in vol. 8, PMID: 28446908.].

Highlights

Specialty section: This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology
Corrigendum: Association of CtLA-4 Gene Variants with response to therapy and Long-term Survival in Metastatic Melanoma Patients treated with ipilimumab: An italian Melanoma intergroup Study
The correct affiliation 9 is “Istituto Dermopatico dell’Immacolata IDI-IRCCS, Rome, Italy”

Summary

Introduction

Specialty section: This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology. Corrigendum: Association of CtLA-4 Gene Variants with response to therapy and Long-term Survival in Metastatic Melanoma Patients treated with ipilimumab: An italian Melanoma intergroup Study

Results

Conclusion